PA
NMTR

PSI Advisors’s 9 Meters Biopharma NMTR Stock Holding History

PSI Advisors’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-300
Closed -$202 – 903
2023
Q2 		$202 Hold
300
– – ﹤0.01% 793
2023
Q1 		$417 Hold
300
– – ﹤0.01% 721
2022
Q4 		$378 Hold
300
– – ﹤0.01% 718
2022
Q3 		$1K Hold
300
– – ﹤0.01% 743
2022
Q2 		$2K Buy
300
+200
+200% +$1.88K ﹤0.01% 687
2022
Q1 		$1K Hold
100
– – ﹤0.01% 710
2021
Q4 		$2K Buy
+100
New +$2.24K ﹤0.01% 683

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIS
Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

PSI Advisors's NMTR Position: Q3 2023 in Review

PSI Advisors sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 300 shares — an estimated $202 sold.

PSI Advisors first reported a position in NMTR in Q4 2021 and held it in 7 quarters. The position peaked at $2K in Q2 2022. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • PSI Advisors reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • PSI Advisors sold 300 9 Meters Biopharma shares in Q3 2023, an estimated $202.
  • PSI Advisors first reported a position in 9 Meters Biopharma in Q4 2021 and held it in 7 quarters.
  • PSI Advisors's 9 Meters Biopharma position peaked at $2K in Q2 2022.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on PSI Advisors's 13F filing for Q3 2023, filed 13 Oct 2023.